Intricon Stock

Intricon Equity

Delisted

The The Equity of Intricon (IIN) as of Sep 9, 2026 is 93.66 M USD. In the previous year, The Equity was 91.16 M USD — a change of 2.73% (higher).

Equity

93.66 MUSD

YoY

2.73%

Last updated:

In 2026, Intricon's equity was 93.66 M USD, a 2.73% increase from the 91.16 M USD equity in the previous year.

The Intricon Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2014
16.11 M USD
Jan 1, 2015
18.90 M USD
Jan 1, 2016
18.56 M USD
Jan 1, 2017
20.92 M USD
Jan 1, 2018
92.23 M USD
Jan 1, 2019
90.75 M USD
Jan 1, 2020
91.16 M USD
Jan 1, 2021
93.66 M USD
The Intricon Equity history
YEAREquityYoY
93.66 MUSD+2.73%
91.16 MUSD+0.46%
90.75 MUSD-1.61%
92.23 MUSD+340.92%
20.92 MUSD+12.72%
18.56 MUSD-1.80%
18.90 MUSD+17.32%
16.11 MUSD
Access this data via the Eulerpool API

Intricon Stock analysis

What does Intricon do? IntriCon Corp is a leading global provider of microelectronic components and solutions for various industries such as medical, energy, audio, communication, and security. The company was founded in 1930 as Intricate Assemblies and is headquartered in Arden Hills, Minnesota, USA. IntriCon has been listed on the NASDAQ stock exchange since 1967. IntriCon is known for its innovative solutions that enable customers to improve the performance and efficiency of their products. The company has extensive manufacturing capabilities in various parts of the world, including the USA, Singapore, Indonesia, and China. IntriCon's business model is based on a custom product range tailored to the specific requirements of industries. IntriCon specializes in developing custom solutions for complex technological problems. The company heavily invests in research and development to find innovative solutions for customers. IntriCon works closely with its customers to ensure that the solutions meet the requirements. IntriCon Corp offers its services in two main business areas: Medical/Healthcare and Hearing Health. In the Medical/Healthcare sector, the company specializes in the development and manufacturing of microelectronic components for medical applications. IntriCon offers its customers a wide range of products, including wireless communication and monitoring systems for patients, hearing aids, implantable medical devices, and high-precision sensors for medical instruments. In the Hearing Health sector, IntriCon specializes in the development and manufacturing of hearing aids and wireless communication systems. IntriCon develops innovative hearing aid technologies that allow customers to achieve higher sound quality and better amplification options. The company also offers wireless communication systems that enable customers to communicate wirelessly with other devices. IntriCon Corp is known for its ability to develop custom solutions for complex technological problems. The company is able to quickly adapt production capacity to respond to changing market demands. The company is also committed to continuously improving the quality of its products to ensure they meet the requirements of its customers. In addition to its main business areas, IntriCon also offers engineering services focused on developing custom solutions. The company leverages its extensive technical expertise to assist customers in developing innovative products, systems, and components. Overall, IntriCon Corp is a leading provider of microelectronic components and solutions for various industries. The company specializes in custom solutions and has extensive manufacturing capabilities in various parts of the world. IntriCon heavily invests in research and development to find innovative solutions for customers. IntriCon is known for its ability to develop custom solutions for complex technological problems and is committed to continuously improving the quality of its products. Intricon is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Intricon's Equity

Intricon's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Intricon's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Intricon's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Intricon's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Intricon’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Intricon stock

The Equity of Intricon is 93.66 M USD in 2026.

The Equity of Intricon changed from 91.16 M USD to 93.66 M USD, representing a 2.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Intricon since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Intricon historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Intricon

All Key Metrics — Intricon